Passive smoking may be associated with bleeding of cerebral arteriovenous malformation in non-smoking women: a retrospective analysis

ABSTRACT

Background Smoking has been considered to be a risk factor for cardiovascular disease, cancer, depression and other diseases in previous reports, and active smoking is considered to be a risk factor for hemorrhagic stroke. In addition, a retrospective study showed that male smokers were at increased risk of bleeding from arteriovenous malformation (AVM), compared with non-smokers. However, the effect of passive smoking on rupturing of cerebral AVM in non-smoking women has not been addressed. Objective This study aimed to assess the impact of tobacco exposure on AVM bleeding risk in non-smoking women. Methods A total of 393 non-smoking women diagnosed with AVM were included. They were divided into a bleeding group (205 women) and a non-bleeding group (188 women). We conducted univariate and multivariate analysis on these two groups. In univariate analysis, risk factors that might be related to AVM bleeding were analyzed. In multivariate analysis, the relationship between passive smoking and AVM rupture was analyzed by correcting confounding factors. Results Multivariate analysis showed that the proportion of passive smoking was statistically different between the bleeding group and the non-bleeding group (OR = 1.609; CI = 1.031-2.509; p = 0.036). Conclusion Passive smoking may increase the risk of AVM bleeding in non-smoking women. This increased risk may be related to the inflammatory response, vascular wall damage, hemodynamic disorders, changes in atherosclerosis and changes in gene expression caused by passive smoking.

RESUMO

Antecedentes O tabagismo tem sido considerado fator de risco para doenças cardiovasculares, câncer, depressão e outras doenças em relatos anteriores, e o tabagismo ativo é considerado fator de risco para acidente vascular cerebral hemorrágico. Além disso, um estudo retrospectivo mostrou que os fumantes do sexo masculino apresentavam risco aumentado de sangramento por malformação arteriovenosa (MAV), em comparação com os não fumantes. No entanto, o efeito do tabagismo passivo na ruptura da MAV cerebral em mulheres não fumantes não foi abordado. Objetivo: Este estudo teve como objetivo avaliar o impacto da exposição ao tabaco no risco de sangramento de MAV em mulheres não fumantes. Métodos Foram incluídas 393 mulheres não fumantes diagnosticadas com MAV. Elas foram divididas em um grupo com sangramento (205 mulheres) e um grupo sem sangramento (188 mulheres). Realizamos análise univariada e multivariada nesses dois grupos. Na análise univariada, foram analisados os fatores de risco que podem estar relacionados ao sangramento de MAV. Na análise multivariada, a relação entre tabagismo passivo e ruptura de MAV foi analisada por meio da correção de fatores de confusão. Resultados A análise multivariada mostrou que a proporção de tabagismo passivo foi estatisticamente diferente entre o grupo com sangramento e o grupo sem sangramento (OR = 1,609; IC = 1,031-2,509; p = 0,036). Conclusão O tabagismo passivo pode aumentar o risco de sangramento de MAV em mulheres não fumantes. Esse risco aumentado pode estar relacionado à resposta inflamatória, danos na parede vascular, distúrbios hemodinâmicos, alterações na aterosclerose e alterações na expressão gênica causadas pelo tabagismo passivo.

Keywords:

Tobacco Smoke Pollution - Hemorrhage - Intracranial Arteriovenous Malformations - Risk

Palavras-chave:

Poluição por fumaça de tabaco - hemorragia - malformações arteriovenosas intracranianas - risco

Authors’ contributions:

JW: data collection, project administration; SZ: conceptualization, formal analysis, methodology, project administration.

Publication History

Received: 16 June 2021

Accepted: 27 August 2021

Article published online:
06 February 2023

• References

• 1 Yang G-H, Li Q, Wang C-X, Hsia J, Yang Y, Xiao L. et al. Findings from 2010 Global Adult Tobacco Survey: implementation of MPOWER policy in China. Biomed Environ Sci 2010; 23 (06) 422-429 https://doi.org/10.1016/S0895-3988(11)60002-0
• 2 Li Z, Yao Y, Yu Y, Shi J, Liu Y, Tao Y. et al. Prevalence and associated factors of passive smoking among women in Jilin Province, China: a cross-sectional study. Int J Environ Res Public Health 2015; 12 (11) 13970-13980 https://doi.org/10.3390/ijerph121113970
• 3 He Y, Lam TH, Jiang B, Wang J, Sai X, Fan L. et al. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked. Circulation 2008; 118 (15) 1535-1540 https://doi.org/10.1161/CIRCULATIONAHA.108.784801
• 4 Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000; 71 (05) 743-751 https://doi.org/10.1902/jop.2000.71.5.743
• 5 Flouris AD, Vardavas CI, Metsios GS, Tsatsakis AM, Koutedakis Y. Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiology Lung Cell Mol Physiol. Am J Physiology Lung Cell Mol Physiol 2010; 298 (01) L3-L12 https://doi.org/10.1152/ajplung.00215.2009
• 6 Bastian LA, Gray KE, DeRycke E, Mirza S, Gierisch JM, Haskell SG. et al. Differences in active and passive smoking exposures and lung cancer incidence between veterans and non-veterans in the women's health initiative. Gerontologist 2016; 56 (Suppl. 01) S102-11 https://doi.org/10.1093/geront/gnv664
• 7 Song C, Li W, Leng J, Wang L, Li W, Shi F. et al. Passive smoking and postpartum depression among Chinese women: a prospective cohort study in Tianjin, China. Women Health 2019; 59 (03) 281-293 https://doi.org/10.1080/03630242.2018.1478365
• 8 Anderson CS, Feigin V, Bennett D, Lin R-B, Hankey G, Jamrozik K. Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) Group. Active and passive smoking and the risk of subarachnoid hemorrhage: an international population-based case-control study. Stroke 2004; 35 (03) 633-637 https://doi.org/10.1161/01.STR.0000115751.45473.48
• 9 Zhang S, Zhou C, Liu D, Piao Y, Zhang F, Hu J. et al. Is smoking a risk factor for bleeding in adult men with cerebral arteriovenous malformations? A single-center regression study from China. J Stroke Cerebrovasc Dis 2020; 29 (09) 105084 https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105084
• 10 Yao T, Sung H-Y, Mao Z, Hu T-W, Max W. The healthcare costs of secondhand smoke exposure in rural China. Tob Control 2015; 24 e3 e221-e226 https://doi.org/10.1136/tobaccocontrol-2014-051621
• 11 Merletti F, Richiardi L, Boffetta P. Med Lav. 1998. 89. 2 149-163
• 12 Xu L, Schooling CM, Chan WM, Lee SY, Leung GM, Lam TH. Smoking and hemorrhagic stroke mortality in a prospective cohort study of older Chinese. Stroke 2013; 44 (08) 2144-2149 https://doi.org/10.1161/STROKEAHA.113.001500
• 13 Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE. et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993; 73 (07) 1423-1434 https://doi.org/10.1016/0092-8674(93)90367-y
• 14 Codd PJ, Mitha AP, Ogilvy CS. A recurrent cerebral arteriovenous malformation in an adult. J Neurosurg 2008; 109 (03) 486-491 https://doi.org/10.3171/JNS/2008/109/9/0486
• 15 Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS. et al. Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 2006; 59 (01) 72-80 https://doi.org/10.1002/ana.20697
• 16 Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003; 170 (06) 3369-3376 https://doi.org/10.4049/jimmunol.170.6.3369
• 17 Yao JS, Zhai W, Fan Y, Lawton MT, Barbaro NM, Young WL. et al. Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells. J Cereb Blood Flow Metab 2007; 27 (03) 510-520 https://doi.org/10.1038/sj.jcbfm.9600365
• 18 Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y. et al. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosc 2006; 11: 3121-3128 https://doi.org/10.2741/2037
• 19 Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998; 3 (01) 21-28 https://doi.org/10.1177/1358836X9800300105
• 20 Bornmyr S, Svensson H. Thermography and laser-Doppler flowmetry for monitoring changes in finger skin blood flow upon cigarette smoking. Clin Physiol 1991; 11 (02) 135-141 https://doi.org/10.1111/j.1475-097X.1991.tb00106.x
• 21 Ernst E, Matrai A, Schmölzl C, Magyarosy I. Dose-effect relationship between smoking and blood rheology. Br J Haematol 1987; 65 (04) 485-487 https://doi.org/10.1111/j.1365-2141.1987.tb04155.x
• 22 Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 2001; 37 (02) 187-193 https://doi.org/10.1161/01.hyp.37.2.187
• 23 Miao Z, Guo M, Zhou S, Sun X, Wang F, Lu H. et al. Smoking and drinking influence the advancing of ischemic stroke disease by targeting PTGS2 and TNFAIP3. Exp Ther Med 2018; 16 (01) 61-66 https://doi.org/10.3892/etm.2018.6138
• 24 Ishiguro-Oonuma T, Ochiai K, Hashizume K, Iwanaga T, Morimatsu M. Nfkbiz regulates the proliferation and differentiation of keratinocytes. Jpn J Vet Res 2015; 63 (03) 107-114 https://doi.org/10.14943/jjvr.63.3.107